MT-401-OTS

· Marker Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MT-401-OTS, covering 2025-12-16 to 2025-12-16. Get the full timeline:

Most recent: Clinical Trial Update: Safety of MT-401-OTS in Patients With Relapsed AML or MDS [Phase 1]